International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical MedicineRegulation (EU) 2024/1689, commonly referred to as the “EU AI Act,” is considered the world’s first comprehensive regulation of artificial intelligence (AI). The webinar will be given by Professor. Dr Folker Spitzenberger who will examine the background, scope, and risk categorisation of AI systems.
Opportunities and challenges of the EU AI Act, such as fostering trust in human-centred AI solutions while avoiding overly stringent regulation, will be discussed, as well as the actual requirements for conformity assessment of AI systems and the interfaces with vertical product regulations such as the European Union Medical Device Regulation (EU MDR) and the European Union In Vitro Diagnostic Regulation (EU IVDR).
Speaker
Professor Folker Spitzenberger is a graduate chemist and received his PhD in molecular biology from the Institute of Pharmacology at Heidelberg University in Germany. After postdoctoral work at the Medical Faculty of the University of Dresden, Germany, and at Yale University (CT, USA), he worked from 2002 to 2016 in the area of assessment and implementation of quality assurance systems in the field of medical devices at the ZLG, the RKI, and the German accreditation body DAkkS.
TIME SCHEDULE
06:00 – 07:00 AM EST
11:00 – 12:00 AM GMT
12.00 – 01:00 PM CET
08:00 – 09:00 PM JST
